In:
International Journal of Cancer, Wiley, Vol. 137, No. 5 ( 2015-09), p. 1128-1135
Kurzfassung:
What's new? Certain long noncoding RNAs (lncRNAs) may be involved in oncogenesis or tumor suppression, raising questions about their potential service as cancer biomarkers. The authors of the present study systematically assessed the diagnostic value of serum‐detectable lncRNAs for gastric cancer (GC) patients. Reverse transcription, quantitative PCR resulted in the identification of a GC‐associated three‐lncRNA signature centering on CUDR, LSINCT‐5 and PTENP1. The three‐lncRNA signature successfully distinguished between early‐stage GC patients and healthy subjects. The findings warrant further investigation of the clinical utility of serum lncRNAs in the detection of early‐stage GC.
Materialart:
Online-Ressource
ISSN:
0020-7136
,
1097-0215
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2015
ZDB Id:
218257-9
ZDB Id:
1474822-8